Lilly confirms date and conference call for second-quarter 2026 financial results announcement
Rhea-AI Summary
Lilly (NYSE: LLY) plans to announce its second-quarter 2026 financial results on August 5, 2026, followed by a conference call with investors and media at 10 a.m. Eastern time. A live webcast and subsequent replay will be accessible via Lilly's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – LLY
On the day this news was published, LLY declined 1.05%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 16 | earnings date notice | Neutral | -0.1% | Announced first-quarter results date and conference call schedule for investors |
| Jan 21 | earnings date notice | Neutral | +3.6% | Announced fourth-quarter results date and conference call schedule for investors |
| Oct 16 | earnings date notice | Neutral | -0.9% | Announced third-quarter results date and conference call schedule for investors |
| Jul 24 | earnings date notice | Neutral | +0.8% | Scheduled second-quarter results announcement and conference call for August |
| Apr 17 | earnings date notice | Neutral | +14.3% | Scheduled first-quarter results announcement and investor conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The five comparable notices had mixed 24-hour reactions: -0.11%, 3.58%, -0.87%, 0.82%, and 14.3%, with a 3.54% average.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Megan MacCauley; maccauley_megan@lilly.com (Media) |
Michael Czapar; czapar_michael_c@lilly.com (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-second-quarter-2026-financial-results-announcement-302831004.html
SOURCE Eli Lilly and Company